Efficacy of extended cefquinome treatment of clinical Staphylococcus aureus mastitis

Journal of Dairy Science

Volumn 96, Issue 8, 2013, Pages 4983-4992

  Swinkels, J M ^a   Cox, P ^b   Schukken, Y H ^c   Lam, T J G M ^d,e  

^a INTERVET INTERNATIONAL BV   (Netherlands)

^b MERCK ANIMAL HEALTH   (United States)

^c College of Veterinary Medicine Cornell University ^*  (United States)

^d GD ANIMAL HEALTH   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Antimicrobial; Dairy cow; Lactation; Mammary gland

Indexed keywords

ANTIINFECTIVE AGENT; CEFQUINOME; CEPHALOSPORIN DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BOVINE MASTITIS; CATTLE; CELL COUNT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DAIRY CATTLE; FEMALE; LACTATION; MAMMARY GLAND; MILK; MULTICENTER STUDY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME; UDDER;

ANTIMICROBIAL; DAIRY COW; LACTATION; MAMMARY GLAND;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CELL COUNT; CEPHALOSPORINS; FEMALE; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE; MILK; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

BOS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 84880627922     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2012-6197     Document Type: Article

References (30)

1. Barkema H.W., Schukken Y.H., Lam T.J.G.M., Beiboer M.L., Wilmink H., Benedictus G., Brand A. Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts. J. Dairy Sci. 1998, 81:411-419.
2. Barkema H.W., Schukken Y.H., Zadoks R.N. Invited review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J. Dairy Sci. 2006, 89:1877-1895.
3. Barlow J.W., White L.J., Zadoks R.N., Schukken Y.H. A mathematical model demonstrating indirect and overall effects of lactation therapy targeting subclinical mastitis in dairy herds. Prev. Vet. Med. 2009, 90:31-42.
4. Bradley A.J., Green M.J. Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations. J. Dairy Sci. 2009, 92:1941-1953.
5. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard 2008, CLSI (Clinical and Laboratory Standards Institute), CLSI document M31-A3. CLSI, Wayne, PA. Third.
6. Deluyker H.A., Van Oye S.N., Boucher J.F. Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows. J. Dairy Sci. 2005, 88:604-614.
7. Guideline on statistical principles for veterinary clinical trials (EMEA/CVMP/816/00-Final). Eur. Agency Eval 2002, EMEA (European Agency for the Evaluation of Medicinal Practices), Med. Pract, London, UK.
8. Guideline for the conduct of efficacy studies for intramammary products for use in cattle (EMEA/CVMP/344/99-Final-Rev. 1) 2003, EMEA (European Agency for the Evaluation of Medicinal Practices), Eur. Agency Eval. Med. Pract, London, UK.
9. Fournier C., Kuhnert P., Frey J., Miserez R., Kirchhofer M., Kaufmann T., Steiner A., Graber H.U. Bovine Staphylococcus aureus: Association of virulence genes, genotypes and clinical outcome. Res. Vet. Sci. 2008, 85:439-448.
10. Gillespie B.E., Moorehead H., Lunn P., Dowlen H.H., Johnson D.I., Lamar K.C., Lewis M.J., Ivey S.J., Hallberg W., Chester S.T., Oliver S.P. Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp. and Staphylococcus aureus intramammary infections in lactating dairy cows. Vet. Ther. 2002, 3:373-380.
11. Haveri M., Taponen S., Vuopio-Varkila J., Salmenlinna S., Pyörälä S. Bacterial genotype affects the manifestation and persistence of bovine Staphylococcus aureus intramammary infection. J. Clin. Microbiol. 2005, 43:959-961.
12. Hendriksen R.S., Mevius D.J., Schroeter A., Teale C., Meunier D., Butaye P., Franco A., Utinane A., Amado A., Moreno M., Greko C., Stark K., Berghold C., Myllyniemi A.L., Wasyl D., Sunde M., Aarestrup F.M. Prevalence of antimicrobial resistance among bacterial pathogens isolated from cattle in different European countries: 2002-2004. Acta Vet. Scand. 2008, 50:28.
13. Holmes M.A., Zadoks R.N. Methicillin resistant S. aureus in human and bovine mastitis. J. Mammary Gland Biol. Neoplasia 2011, 16:373-382.
14. Jarp J., Bugge H.P., Larsen S. Clinical trial of three therapeutic regimens for bovine mastitis. Vet. Rec. 1989, 124:630-634.
15. Melchior M.B., Vaarkamp H., Fink-Gremmels J. Biofilms: A role in recurrent mastitis infections?. Vet. J. 2006, 171:398-407.
16. Laboratory Handbook on Bovine Mastitis 1999, National Mastitis Council, Natl. Mastitis Counc. Inc., Madison, WI.
17. Neave F.K., Dodd F.H., Kingwill R.G., Westgarth D.R. Control of mastitis in the dairy herd by hygiene and management. J. Dairy Sci. 1969, 52:696-707.
18. Olde Riekerink R.G.M., Barkema H.W., Scholl D.T., Poolea D.E., Keltond D.F. Management practices associated with the bulk-milk prevalence of Staphylococcus aureus in Canadian dairy farms. Prev. Vet. Med. 2010, 97:20-28.
19. Oliver S.P., Gillespie B.E., Headrick S.J., Moorehead H., Lunn P., Dowlen H.H., Johnson D.L., Lamar K.C., Chester S.T., Mosely W.M. Efficacy of extended ceftiofur intramammary therapy for treatment of subclinical mastitis in lactating dairy cows. J. Dairy Sci. 2004, 87:2393-2400.
20. Osterås O., Edge V.L., Martin S.W. Determinants of success or failure in the elimination of major mastitis pathogens in selective dry cow therapy. J. Dairy Sci. 1999, 82:1221-1231.
21. Pyörälä S.H.K., Pyörälä E.O. Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis; 487 cases (1989-1995). J. Am. Vet. Med. Assoc. 1998, 212:407-412.
22. Roy J.P., DesCÔteaux L., DuTremblay D., Beaudry F., Elsener J. Efficacy of a 5-day extended therapy program during lactation with cephapirin sodium in dairy cows chronically infected with Staphylococcus aureus. Can. Vet. J. 2009, 50:1257-1262.
23. Sampimon O., van den Borne B.H., Santman-Berends I., Barkema H.W., Lam T.J.G.M. Effect of coagulase-negative staphylococci on somatic cell count in Dutch dairy herds. J. Dairy Res. 2010, 77:318-324.
24. Sampimon O.C., Lam T.J.G.M., Mevius D.J., Schukken Y.H., Zadoks R.N. Antimicrobial susceptibility of coagulase-negative staphylococci isolated from bovine milk samples. Vet. Microbiol. 2011, 150:173-179.
25. Sol J., Sampimon O.C., Barkema H.W., Schukken Y.H. Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus. J. Dairy Sci. 2000, 83:278-284.
26. Sol J., Sampimon O.C., Snoep J.J., Schukken Y.H. Factors associated with bacteriological cure during lactation after therapy for subclinical mastitis caused by Staphylococcus aureus. J. Dairy Sci. 1997, 80:2803-2808.
27. Vanderhaeghen W., Cerpentier W., Adriaensen C., Vicca J., Hermans K., Butaye P. Methicillin-resistant Staphylococcus aureus (MRSA) ST398 associated with clinical and subclinical mastitis in Belgian cows. Vet. Microbiol. 2010, 144:166-171.
28. Walker J.B., Rajala-Schultz P.J., DeGraves F.J. The effect of inoculum volume on the microbiologic detection of naturally occurring Staphylococcus aureus intramammary infections. J. Vet. Diagn. Invest. 2010, 22:720-724.
29. Zadoks R.N., Allore H.G., Barkema H.W., Sampimon O.C., Wellenberg G.J., Grohn Y.T., Schukken Y.H. Cow- and quarter-level risk factors for Streptococcus uberis and Staphylococcus aureus mastitis. J. Dairy Sci. 2001, 84:2649-2663.
30. Zadoks R., van Leeuwen W., Barkema H., Sampimon O.C., Verbrugh H., Schukken Y.H., van Belkum A. Application of pulsed-field gel electrophoresis and binary typing as tools in veterinary clinical microbiology and molecular epidemiologic analysis of bovine and human Staphylococcus aureus isolates. J. Clin. Microbiol. 2000, 38:1931-1939.